Corcept Therapeutics (CORT) Capital Expenditures Growth (1y) (2013 - 2026)
Corcept Therapeutics (CORT) Capital Expenditures Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Corcept Therapeutics | 9.56 Bn | 9.22 Bn | 162.02 Mn | 93.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.27% |
| Dec 31, 2025 | -58.68% |
| Jun 30, 2025 | -86.30% |
| Sep 30, 2024 | 4,318.92% |
| Jun 30, 2024 | 307.84% |
| Sep 30, 2023 | -89.46% |
| Jun 30, 2023 | 436.84% |
| Dec 31, 2022 | -52.31% |
| Sep 30, 2022 | 120.75% |
| Jun 30, 2022 | -84.03% |
| Mar 31, 2022 | -90.48% |
| Dec 31, 2021 | -84.92% |
| Sep 30, 2021 | -77.86% |
| Jun 30, 2021 | 153.19% |
| Mar 31, 2021 | 200.00% |
| Dec 31, 2020 | 219.26% |
| Sep 30, 2020 | 151.05% |
| Jun 30, 2020 | -88.54% |
| Mar 31, 2020 | -83.66% |
| Dec 31, 2019 | 19.47% |